(2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone, 95.0%, 100g

(R)-2-((tert-butoxycarbonyl)amino)-2-(naphthalen-2-yl)acetic acid, 95%, 1g

2-tert-Butyloxycarbonylaminomethyl-5-thiophen-2-yl-[1,3,4]oxadiazole, 95.0%, 1g

Tributylsulfonium iodide, 97%, 1g

1-(3,4-Dichlorophenyl)butan-1-amine hydrochloride, 95%, 2.5g

Benzenepentacarboxylic Acid>98.0%(HPLC)(T)5g

3-Isobutylglutaric acid, 95.0%, 1g

Direct displacement pipette MICROMAN® E, 10 to 100 µl, 1 piece

1-(tert-Butyl) 2-methyl 5-hydroxypiperidine-1,2-dicarboxylate, 98%, 1g

3-Bromo-1,1,1-trifluoro-hexan-2-one, 250mg

2-(4-Chlorophenoxy)-2-methylpropanoic acid, 95.0%, 250g

Dibenzofuran-4-boronic acid, 98.0%, 500mg

4-(1,3-DIOXOLAN-2-YL)BENZALDEHYDE, 95.0%, 1g